Secretome Therapeutics
Secretome Therapeutics
secretometherapeutics.com
Locations
Baltimore, MD, USA
industry
Biotechnology · Biotechnology Research · Health Care · Medical · Therapeutics
Size
1 - 10 employees
Stage
Pre Seed
founded in
2018
About

Secretome Therapeutics is a clinical-stage cell therapy company focused on orphan and underserved cardiac diseases. STM-01, the lead drug, is a neonatal cardiac progenitor cell (nCPC) isolated from cardiac tissue excised during life-saving, open-heart surgery on newborns with congenital heart defects. The main target indication for STM-01 is Duchenne muscular dystrophy-associated cardiomyopathy (DMD-CM).

Something looks off?
Open jobs at Secretome Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.